I think that answers it well enough. Big pharma buys a lot of leads from small pharma, but I think small pharma could fill the pipeline pretty well without ruthlessly exploiting it quite as much.
I wasn’t sure if you were a natural remedy type nut. I now take your statement to be hyperbole since a lot of people die from car accidents. Only some of those can be blamed on big pharma making a treatment too expensive or getting the other driver addicted.
That’s an odd question without an easy answer. And the question is vague enough that it probably doesn’t warrant a serious answer.
“Small pharma” plays many roles. One of the most basic is working with “big pharma,” whether in research or manufacturing commercial products.
But I’m going on 30 years on the scientific side of this business, so I’m trying to avoid going into a whole spiel on the topic.
I think that answers it well enough. Big pharma buys a lot of leads from small pharma, but I think small pharma could fill the pipeline pretty well without ruthlessly exploiting it quite as much.
I wasn’t sure if you were a natural remedy type nut. I now take your statement to be hyperbole since a lot of people die from car accidents. Only some of those can be blamed on big pharma making a treatment too expensive or getting the other driver addicted.